
Biocon Ltd. is Rated Sell by MarketsMOJO
2026-11-14 10:10:41Biocon Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 11 November 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 November 2026, providing investors with the latest insights into the company’s performance and outlook.
Read MoreBiocon Gains 3.69% This Week: Earnings Slump and Intraday Rally Shape the Story
2026-11-08 14:00:10Key Events This Week 2 Nov: Stock opens at Rs.353.85 with modest gains 3 Nov: Sharp decline of 2.97% amid broader market gains 5 Nov: Intraday high of Rs.363.40 with 5.28% surge; Q2 earnings reveal sharp profit decline 6 Nov: Week closes at Rs.365.00, up 1.00% on the day Week OpenRs.352.00 Week Close<div class="stat-v...
Read More
Biocon Ltd. Rallies 5.28% and Approaches 50 DMA Resistance — A Key Technical Test Ahead
2026-11-05 10:41:27The Sensex gained 1.85% on 05 Nov 2026, yet Biocon Ltd. outperformed with a 5.28% surge, touching an intraday high of Rs 363.4. That 3.43-percentage-point outperformance signals a stock-specific strength rather than a mere market tailwind.
Read More
Biocon Ltd Q2 2026 Earnings Reveal Sharp Decline Amid Negative Financial Trend
2026-11-05 08:00:13Biocon Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has reported a marked deterioration in its latest quarterly financial performance, signalling a shift from a previously flat trend to a distinctly negative trajectory. Despite a robust growth in profit after tax over the last six months, the September 2026 quarter results reveal significant contraction in key profitability metrics, raising concerns among investors and analysts alike.
Read More
Biocon Ltd Sees Sharp Open Interest Surge Amid Mixed Market Signals
2026-10-26 15:00:09Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 24.46% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite trading near its 52-week low, the stock outperformed its sector on 26 Oct 2026, reflecting a complex interplay of cautious optimism and strategic bets among traders.
Read More
Biocon Ltd Sees Sharp Open Interest Surge Amid Mixed Market Signals
2026-10-26 14:00:10Biocon Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 18% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite trading near its 52-week low, the stock’s recent uptick after a prolonged decline and increased delivery volumes suggest a complex interplay of cautious optimism and speculative bets among traders.
Read MoreBiocon Ltd. Declines 6.69%: Four Key Factors Behind the Steep Weekly Drop
2026-10-25 14:00:37Key Events This Week Oct 19: Technical momentum shifts to bearish amid market pressure Oct 21: Stock falls to 52-week low of Rs.337.7 Oct 22: New 52-week low of Rs.328.65 recorded Oct 23: Week closes at Rs.326.60 after fresh 52-week low of Rs.327 Week OpenRs.340.50 Week CloseRs.326.60<div...
Read More
Biocon Ltd. is Rated Sell by MarketsMOJO
2026-10-23 10:10:03Biocon Ltd. is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 October 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.
Read MoreAnnouncement under Regulation 30 (LODR)-Press Release / Media Release
18-Nov-2026 | Source : BSEPress Release
Announcement under Regulation 30 (LODR)-Press Release / Media Release
16-Nov-2026 | Source : BSEPress Release
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
11-Nov-2026 | Source : BSEIntimation on Schedule of Meetings with Analyst(s)/institutional Investor(s)
Corporate Actions
No Upcoming Board Meetings
Biocon Ltd. has declared 10% dividend, ex-date: 03 Jul 26
No Splits history available
Biocon Ltd. has announced 1:1 bonus issue, ex-date: 12 Jun 19
No Rights history available
